Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Apr;59(4):373-5.

Clinically important interaction between metoprolol and propafenone

Jana Duricova  1 , Ilona Perinova, Nikola Jurckova, Ivana Kacirova, Milan Grundmann
Affiliations
Case Reports

Clinically important interaction between metoprolol and propafenone

Jana Duricova et al. Can Fam Physician. 2013 Apr.
No abstract available

PubMed Disclaimer

References

    1. Kroemer HK, Fischer C, Meese CO, Eichelbaum M. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. Mol Pharmacol. 1991;40(1):135–42. - PubMed
    1. Otton SV, Inaba T, Kalow W. Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Sci. 1984;34(1):73–80. - PubMed
    1. Frank D, Jaehde U, Fuhr U. Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol. 2007;63(4):321–33. Epub 2007 Feb 2. - PubMed
    1. Abrahamsson B, Lücker P, Olofsson B, Regårdh CG, Sandberg A, Wieselgren I, et al. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations. J Clin Pharmacol. 1990;30(2 Suppl):S46–54. - PubMed
    1. Regårdh CG, Johnsson G. Clinical pharmacokinetics of metoprolol. Clin Pharmacokinet. 1980;5(6):557–69. - PubMed

Publication types

MeSH terms

LinkOut - more resources